Medical News

RSS

EI trumps IQ reveals how well dental students work with patients

IQ directly relates to how students perform on tests in the first two years of dental school. But emotional intelligence trumps IQ in how well dental students work with patients, report researchers from Case Western Reserve University's School of Dental Medicine and Weatherhead School of Management.

23 Apr 2013

OHSU, Intel team up to develop technologies to make personalized genomic analysis faster

Oregon Health & Science University and Intel Corp. are teaming up to develop next-generation computing technologies that advance the field of personalized medicine by dramatically increasing the speed, precision and cost-effectiveness of analyzing a patient's individual genetic profile.

23 Apr 2013

Global Fund working to fight malaria in Latin America

In the ONE blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes about how the Global Fund to Fight AIDS, Tuberculosis and Malaria is working to prevent malaria in Latin America.

23 Apr 2013

Biological Psychiatry special issue tackles the question on food addiction

Biological Psychiatry is proud to announce this week's publication of a special issue focusing on the question of food as an addiction.

23 Apr 2013

BAROnova presents ENDObesity I clinical trial data at SAGES meeting

BAROnova, Inc., recently presented data from their ENDObesity I clinical trial at the annual Society of American Gastrointestinal and Endoscopic Surgeons meeting.

23 Apr 2013

Experts call for better vaccine supply, logistics systems ahead of World Immunization Week

In recognition of World Immunization Week, which began April 21, the WHO "is calling on nations to help immunize more children against preventable diseases so more lives can be saved," VOA News reports, noting the U.N. health agency "estimates immunization saves the lives of two to three million children every year."

23 Apr 2013

TSRI scientists find way to directly turn bone marrow stem cells into brain cells

In a serendipitous discovery, scientists at The Scripps Research Institute have found a way to turn bone marrow stem cells directly into brain cells.

23 Apr 2013

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.

23 Apr 2013

Repeated plastic surgery required for dog bites to the face in children: Report

Dog bites to the face are a relatively common injury in young children, and often require repeated plastic surgery procedures to deal with persistent scarring, according to a report in the March Journal of Craniofacial Surgery, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

23 Apr 2013

Britain to 'stand together' with other stakeholders to eradicate polio

"[V]accinations play a huge part in deciding a country's long-term health," and "[t]he more healthy a population, the better able it is to contribute to and benefit from economic development," British Secretary of State for International Development Justine Greening writes in an Independent opinion piece.

23 Apr 2013

$Johns Hopkins researchers find that diagnostic errors accounted for largest fraction of claims$

Johns Hopkins researchers find that diagnostic errors accounted for largest fraction of claims

In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.

23 Apr 2013

Senesco completes cohort 2 in Phase 1b/2a clinical study of SNS01-T

Senesco Technologies, Inc. reported today that it has completed cohort 2 in its Phase 1b/2a clinical study of SNS01-T.

23 Apr 2013

Merck, Bristol-Myers Squibb to evaluate daclatasvir and MK-5172 for treatment of HCV infection

Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.

23 Apr 2013

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Gold nanoparticles are tiny spherical particles made out of gold atoms with sizes on nanometre scale. This is around 1,000 times smaller than the thickness of human hair.

23 Apr 2013

FDA wants to understand physician experiences with direct-to-consumer ads

The FDA will survey healthcare providers about their experience with direct-to-consumer advertising in order to assess its impact on their practice after receiving White House clearance for the program this week.

23 Apr 2013

Integral Molecular releases MPS antibody discovery platform

ntegral Molecular, Inc., a leader in membrane protein reagents and services, announces the launch of its Membrane Protein Solutions antibody discovery platform.

23 Apr 2013

BioInvent starts BI-505 phase II study in patients with smoldering multiple myeloma

BioInvent International announced today that the first patient has been treated in a phase II study of the drug candidate BI-505, developed for the treatment of multiple myeloma.

23 Apr 2013

Stratified Medicine Scotland Innovation Centre (SMS-IC) receives funding from the Scottish Funding Council

The University of Glasgow is set to boost its contribution to global medical research and the Scottish economy following the announcement of funding to build a major research centre.

23 Apr 2013

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).

From Medtronic 23 Apr 2013

Viewpoints: Solving the doctor shortage; Can Gov. Scott convince Fla. lawmakers to accept Medicaid expansion?

With every new report about the recent slowdown in health-care spending there is speculation in the media that the problem of rising health costs has somehow been solved or cut down to size.

23 Apr 2013

Medical News

EI trumps IQ reveals how well dental students work with patients

OHSU, Intel team up to develop technologies to make personalized genomic analysis faster

Global Fund working to fight malaria in Latin America

Biological Psychiatry special issue tackles the question on food addiction

BAROnova presents ENDObesity I clinical trial data at SAGES meeting

Experts call for better vaccine supply, logistics systems ahead of World Immunization Week

TSRI scientists find way to directly turn bone marrow stem cells into brain cells

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Repeated plastic surgery required for dog bites to the face in children: Report

Britain to 'stand together' with other stakeholders to eradicate polio

Johns Hopkins researchers find that diagnostic errors accounted for largest fraction of claims

Senesco completes cohort 2 in Phase 1b/2a clinical study of SNS01-T

Merck, Bristol-Myers Squibb to evaluate daclatasvir and MK-5172 for treatment of HCV infection

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

FDA wants to understand physician experiences with direct-to-consumer ads

Integral Molecular releases MPS antibody discovery platform

BioInvent starts BI-505 phase II study in patients with smoldering multiple myeloma

Stratified Medicine Scotland Innovation Centre (SMS-IC) receives funding from the Scottish Funding Council

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

Viewpoints: Solving the doctor shortage; Can Gov. Scott convince Fla. lawmakers to accept Medicaid expansion?

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News